Cramer's 'Mad Money' Recap: Learning From Mistakes (Update 2)

to sell, said Cramer, it was the time to buy. While there was indeed a lull in sales, Medco's long-term thesis remained in tact. In the days that followed, Medco recovered $4.68 from its low, and still trades at only 12.5 times earnings. Teva...